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Introduction
Glutamine synthetase [GS; L-glutamate-ammonia ligase (ADP
forming); EC6.3.1.2] catalyzes the ATP-dependent formation of
glutamine from glutamate and ammonia and therefore plays an
important role in ammonia detoxification and in the recycling of
the neurotransmitter glutamate. In neural tissues, GS expression is
confined to astrocytes and is cytoplasmic in all examined vertebrates
(Kennedy et al., 1974; Linser and Moscona, 1983; Smith and
Campbell, 1983; Smith and Campbell, 1987). However, the
subcellular localization of GS in liver cells is dependent on the
ammonia detoxification system used. In higher vertebrates, such as
mammals, which utilize the ureotelic system of ammonia-
detoxification, GS is cytoplasmic in cells of both liver and neural
tissue (Smith and Campbell, 1988; Wu, 1963). By contrast, in the
marine elasmobranchs, such as dogfish shark, which utilize the
ureosmotic system of ammonia detoxification, GS is cytoplasmic
in neural tissue but mitochondrial in liver cells (Smith et al., 1987).
Mitochondrial localization of hepatic GS is also required for the
uricotelic system of ammonia detoxification. This system has
apparently evolved as a water-conserving mechanism in the
dinosaurs and their kin, and is utilized today by several species
including birds (Campbell et al., 1987). In this system,
intramitochondrially created ammonia is converted to glutamine by
the action of GS, and this is followed by synthesis of the excreted
final product, uric acid (Vorhaben and Campbell, 1972). The
hepatic GS in these species is confined to the mitochondrial matrix
of all liver cells (Smith and Campbell, 1987; Vorhaben and
Campbell, 1972; Vorhaben and Campbell, 1977). Thus, uricotelic
and ureosmotic vertebrates share a common trait of targeting the
GS enzyme to the mitochondria in liver cells and cytoplasm in neural
tissue.
Proteins targeted to the mitochondrial matrix are often expressed
as a pre-polypeptide with an N-terminal extension that contains a
mitochondrial targeting signal (MTS). These targeting presequences
are commonly between 10 and 80 amino acids long and are capable
of forming an amphipathic -helix that is rich in basic and hydroxyl
residues and lacks acidic residues (von Heijne, 1986). Import into
the matrix is dependant on two energy sources: the mitochondrial
membrane potential (), which exerts an electrophoretic pulling
force on the positively charged MTS, and ATP hydrolysis in the
matrix (Mokranjac and Neupert, 2008). Once inside the matrix, the
MTS sequences are proteolytically cleaved, although in a number
of cases the signals remain uncleaved (Neupert, 1997).
In the dogfish shark, which utilizes the ureosmotic system for
ammonia detoxification, we have recently found that the differential
targeting of GS is achieved by tissue-specific alternative splicing
(Matthews et al., 2005). This species contains a single GS gene,
but express two isoforms of the GS protein: a large isoform that
occurs mainly in the mitochondrial compartment of liver cells, and
a smaller isoform in the cytoplasm of brain cells (Laud and
Campbell, 1994). The formation of neural and liver isoforms and
their differential subcellular localization is controlled by an
alternative splicing process, which generates two different GS
transcripts (Matthews et al., 2005). The liver transcript contains an
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Summary
Evolution of the uricotelic system for ammonia detoxification required a mechanism for tissue-specific subcellular localization of
glutamine synthetase (GS). In uricotelic vertebrates, GS is mitochondrial in liver cells and cytoplasmic in brain. Because these species
contain a single copy of the GS gene, it is not clear how tissue-specific subcellular localization is achieved. Here we show that in
chicken, which utilizes the uricotelic system, the GS transcripts of liver and brain cells are identical and, consistently, there is no
difference in the amino acid sequence of the protein. The N-terminus of GS, which constitutes a ‘weak’ mitochondrial targeting signal
(MTS), is sufficient to direct a chimeric protein to the mitochondria in hepatocytes and to the cytoplasm in astrocytes. Considering
that a weak MTS is dependent on a highly negative mitochondrial membrane potential () for import, we examined the magnitude
of  in hepatocytes and astrocytes. Our results unexpectedly revealed that  in hepatocytes is considerably more negative than that
of astrocytes and that converting the targeting signal into ‘strong’ MTS abolished the capability to confer tissue-specific subcellular
localization. We suggest that evolutional selection of weak MTS provided a tool for differential targeting of an identical protein by
taking advantage of tissue-specific differences in .
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alternative exon that is not present in the neural one. This exon
leads to acquisition of an upstream in-frame start codon (uAUG),
the addition of 29 residues to the N-terminus of the molecule, and
formation of a MTS. Therefore, the liver product is targeted to the
mitochondria, whereas the neural one is retained in the cytoplasm.
Chicken, which utilize the uricotelic system for ammonia
detoxification, also contain a single copy of the GS gene (Patejunas
and Young, 1987) and target the GS enzyme to the mitochondria
in liver cells and to cytoplasm in neural tissue. Although regulation
of GS expression in chicken has been extensively studied in the
past (for a review, see Vardimon et al., 1999), the mechanism for
differential targeting of GS remained largely unknown. Here we
show that in chicken, unlike dogfish shark, tissue-specific
subcellular localization is not achieved by alternative splicing, but
rather by a novel mechanism that can differentially target an identical
protein to the mitochondria in hepatocytes and to cytoplasm in
astrocytes. This mechanism relies on the evolutional selection of a
‘weak’ MTS, which is known to depend on a highly negative 
for import. We show that the  in hepatocytes is considerably
more negative than in astrocytes and that converting the targeting
signal of GS into ‘strong’ MTS abolished the capability to confer
tissue-specific subcellular localization. Thus, although the GS gene
has been highly conserved during evolution, the mechanism for
tissue-specific subcellular localization has evolved independently
twice.
Results
Differential targeting of chicken GS in liver and brain cells
is not achieved by alternative splicing
Differential targeting of chicken GS was microscopically observed
following immunostaining of monolayer cultures of primary
hepatocytes and astrocytes with anti-GS antibody and with
MitoTracker (a mitochondrial marker). In agreement with previous
studies (Smith and Campbell, 1983), GS was mitochondrial in
hepatocytes and cytoplasmic in astrocytes (Fig. 1A). Similar results
were also obtained by western blot analysis of mitochondrial and
cytoplasmic fractions of liver and brain tissues, using antibodies
against the mitochondrial protein mHsp60 and the cytoplasmic
protein tubulin as controls. Here too, accumulation of GS was
mitochondrial in liver cells and cytoplasmic in the brain (Fig. 1B).
As described above, differential targeting of GS in liver and neural
tissue in marine elasmobranchs such as dogfish shark is achieved
by an alternative splicing: the liver cell splice product encodes a
MTS, whereas the neural tissue splice product lacks this sequence
(Matthews et al., 2005). To determine whether this GS targeting
mechanism has been evolutionary conserved, we examined the
possible presence of differentially spliced GS transcripts in chicken
liver and brain. Northern blot analysis revealed no size difference
between GS transcripts from the two tissues (Fig. 2A). Similarly,
RT-PCR products obtained by using primers for exon 1 and 7, the
two end exons of the GS gene, displayed no difference in size (Fig.
2B). This is consistent with a previous report that demonstrated
that sequences of two cloned GS cDNAs from chicken liver and
brain were identical (Campbell and Smith, 1992). Yet, considering
that a cDNA clone represents a single transcript, this finding does
not exclude the possibility that liver cells contain other GS
transcripts that differ from those of brain. Signals that target proteins
Journal of Cell Science 123 (3)
Fig. 1. Avian GS is mitochondrial in hepatocytes and cytoplasmic in
astrocytes. (A)Chicken hepatocytes and astrocytes were stained with
antibodies against GS and mitochondria were stained using MitoTracker.
Confocal images show GS staining, mitochondria staining and overlay of GS
and mitochondria staining, as indicated. When GS localizes to mitochondria,
the green and red colors merge and yellow appears in overlay images.
(B)Western blot analysis of chicken liver and brain subcellular fractions.
Equivalent portions from the total (T), cytoplasmic (C) and mitochondrial (M)
fractions were analyzed using the indicated antibodies.
Fig. 2. The GS transcript of liver cells is not different from that of brain.
(A)Northern blot analysis of chicken brain and liver GS mRNA using a
specific [32P] probe. (B)RT-PCR analysis of chicken brain and liver mRNA
using primers for exon 1 and exon 7 of the GS gene. (C)Schematic
representation of the first two GS exons and their intermediary intron. Labeled
open reading frames (ORFs) found to encode potential MTS are indicated.
Numbers below give location of the exons and ORFs on the gene relative to
the transcription initiation site. The primers used for RT-PCR and PCR
analysis are shown as numbered arrows with arrowhead indicating the 3 end.
(D)Results of RT-PCR on liver (lanes 7-12) and brain (lanes 13-18) RNA and
PCR on the genomic clone pGS-116 (lanes 1-6) as a control, using the
indicated primers. The bands representing the GS transcript in liver and brain
are indicated by an arrow.
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to the mitochondrial matrix are usually encoded by the 5 region
of the transcript. This is the case in dogfish shark, where GS contains
the initiator AUG codon in exon 2 and an alternative exon of only
95 bases, which leads to acquisition of a mitochondrial targeting
signal in intron 1 (Matthews et al., 2005). Because the initiator AUG
codon of chicken GS is also located in exon 2, we examined the
possible presence of an upstream alternative exon. To this end, we
sequenced intron 1 of the GS gene (GenBank accession no.
EU369427) using the chicken genomic GS clone pGS116 (Vardimon
et al., 1986), and subjected the sequence to analysis by MTS
prediction programs (PsortII, MitoprotII, Predotar, Mitopred and
TargetP). Several potential MTS regions were identified within
intron 1 (Fig. 2C). PCR or RT-PCR analysis, using primers for
sequences upstream or inside the potential MTS regions, generated
products of anticipated sizes on the genomic GS clone (Fig. 2D,
lanes 2-6), but not on liver or brain RNA (Fig. 2D, lanes 8-12 and
14-18). Consistently, RT-PCR analysis using primers for exon 1
and 2 resulted in a single fragment in both liver and brain (Fig. 2D,
lanes 7 and 13, indicated by an arrow) that corresponded to the size
predicted from splicing out of the whole intron 1 region. Taken
together, these findings suggest that chicken liver and brain cells
contain an identical GS transcript and that tissue-specific subcellular
localization of chicken GS is not achieved by a mechanism of
alternative splicing as found in elasmobranchs.
The N-terminus of chicken GS is sufficient to confer
tissue-specific subcellular localization
Differential targeting of a protein product might also be achieved
by alternative initiation of translation, which leads to the production
of proteins that differ in their N-terminal domain and molecular
mass. However, Western blot analysis revealed no size difference
between liver and brain GS (Fig. 3A). Considering that the N-
terminus of mitochondrial proteins is often cleaved on entry into
the mitochondrial matrix, the difference between liver and brain
GS might be diminished and not detectable by western blot analysis.
Therefore, we compared sequences of the GS protein from brain
and liver using mass spectrometry. Liver and brain GS were isolated
by immunoprecipitation (Fig. 3B), cleaved with trypsin, AspN or
GluC and subjected to analysis by mass spectrometry (Fig. 3C).
We obtained coverage of 68% of the primary GS sequence (Fig.
3C, underlined) including the first 85 residues at the N-terminal of
the protein. The results revealed that the N-terminus of liver GS is
not cleaved on mitochondrial translocation and that the detected
amino acid sequences of liver and brain GS are identical. In both
Fig. 3. The GS protein in liver cells is identical to that in brain. (A)Cellular
protein samples were prepared from liver and brain and analyzed by western
blot using anti-GS antibodies. (B)Protein samples from brain (lanes 1,3) and
liver (lanes 2,4) were immunoprecipitated with anti GS antibodies (lanes 3,4)
or non-specific antibodies (NS, lanes 1,2) and resolved on SDS-PAGE. The
GS bands (marked by arrows) were excised and used for analysis by mass
spectrometry. Lane M shows a mixture of proteins used as standards. (C)The
sequence of chicken GS protein. In bold and underlined are the sections
identified by mass spectrometry sequencing.
Fig. 4. The N-terminus of chicken GS
confers differential localization in
hepatocytes and astrocytes. Hepatocytes
and astrocytes were transfected with the
chimeric constructs pCh-50N-EGFP,
pEGFP-Ch-50C, pDf-MTS-EGFP or with
pEGFP-N1, as indicated. Mitochondria were
stained using MitoTracker. Confocal images
show mitochondrial staining, EGFP
localization and overlay of EGFP and
mitochondrial staining, as indicated. When
EGFP localizes to mitochondria, the green
and yellow colors merge and yellow appears
in overlay images.
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tissues, the initial methionine was removed and, apart from
acetylation of alanine at position 2, no other post-translational
modifications in the sequenced fragments were detected.
Most mitochondrial matrix proteins carry N-terminal targeting
sequences, termed MTS, although some might contain MTS
sequences in the C-terminal domain (Folsch et al., 1998; Lee et al.,
1999). To probe the existence of an N- or C-terminal mitochondrial
targeting signal in chicken GS, we fused the first 50 N-terminal or
the last 50 C-terminal residues of the protein upstream (pCh-50N-
EGFP) or downstream (pEGFP-Ch-50C) to the reading frame of
the reporter EGFP, respectively. As controls, we used the reporter
construct that contains the MTS sequence of dogfish shark GS fused
in frame to EGFP [pDf-MTS-EGFP (Matthews et al., 2005)], and
the EGFP reporter alone (pEGFP-N1). Monolayer cultures of
hepatocytes and astrocytes were transfected with the different
constructs, and the subcellular localization of the chimeric proteins
was assayed. The cells were stained with MitoTracker to identify
mitochondrial localization. It should be noted that not all cells are
transfected and consequently more cells are seen stained with
MitoTracker than express EGFP. In cells transfected with the
pEGFP-N1 construct, EGFP was homogenously distributed in the
cytoplasm and nucleus of both hepatocytes and astrocytes (Fig. 4C).
A similar pattern was observed in cells transfected with the chimeric
C-terminal construct, p-EGFP-Ch-50C (Fig. 4A). There too, the
chimeric EGFP was homogenously distributed in hepatocytes and
astrocytes, indicating that the attached GS residues did not contain
a localization signal. By contrast, transfection of the N-terminal
pCh-50N-EGFP construct resulted in a cell-type-specific distribution
of EGFP (Fig. 4D): similarly to the endogenous GS, this Ch-50N-
EGFP was mitochondrial in hepatocyte cells, but mainly
cytoplasmic in astrocytes. This cell-type-specific distribution was
not due to an intrinsic failure of astrocytes to transport EGFP to
the mitochondria because pDf-MTS-EGFP (harboring the dogfish
MTS) was mitochondrial in both hepatocytes and astrocytes (Fig.
4B).
Next, we examined whether GS can be imported into liver
mitochondria in a standard in vitro import reaction. Purified chicken
liver mitochondria were isolated and incubated with in vitro
translated GS. Import into mitochondria was determined by
resistance to externally added proteinase K. We detected essentially
no import of GS or of GS-DHFR (GS N-terminal 50 amino acid
residues fused to DHFR) (Fig. 5A, bottom and top left panels,
respectively). By contrast, Su9-DHFR, a known control of
mitochondrial matrix targeting that is cleaved upon entry (Karniely
et al., 2006) (Fig. 5A, top right panel), or Su9-GS (Fig. 5A, bottom
right panel) were imported efficiently. Similar results were obtained
when import was assayed under coupled translation and import
conditions (Knox et al., 1998), in the presence of elevated
concentrations of NADH (8 mM), ATP (4 mM) or succinate (4 mM)
or following denaturation with urea (not shown). These findings
suggest that the N-terminal residues of chicken GS establish a non-
conventional MTS that requires for import mitochondrial properties
and/or cellular components not available in an in vitro system.
Mitochondrial membrane potential in hepatocytes is more
negative than in astrocytes
Tissue-specific modification of MTS residues represents an
attractive mechanism for differential targeting of GS. Considering
that phosphorylation of MTS residues has been shown to affect
mitochondrial import (Amutha and Pain, 2003;
Anandatheerthavarada et al., 1999; Robin et al., 2003), we decided
to examine the possible involvement of tissue-specific
phosphorylation in differential targeting of GS. Inspection of the
GS N-terminal 50 amino acid sequence, using a program that
predicts Ser/Thr/Tyr phosphorylation sites (NetPhos), revealed two
main candidates for phosphorylation: Tyr17 and Ser7. Substitution
of Tyr17 with the phosphor-mimetic Glu residue (pCh-50N-
EGFPY17E) was indeed sufficient to impair mitochondrial import:
the chimeric protein was cytoplasmic not only in astrocytes, but in
hepatocytes as well (Fig. 5B). By contrast, substitution of Tyr17 or
Ser7 with Ala (pCh-50N-EGFPS17A or pCh-50N-EGFPY17A,
respectively), an amino acid residue that cannot accept a phosphor
group, had no effect on the subcellular localization of the chimeric
protein: in both cases EGFP was mitochondrial in hepatocytes and
cytoplsmic in astrocytes (Fig. 5B). These finding suggested that
tissue specificity is not facilitated by differential phosphorylation
of these residues. In agreement, MS/MS analysis did not detect
phosphorylated residues in brain or liver GS and no phosphorylation
was observed by western blot analysis of immunoprecipitated GS
molecules using anti phospho-tyrosine Abs (not shown).
Another possible mechanism for differential targeting of GS is
based on the fact that translocation of mitochondrial proteins across
the inner mitochondrial membrane is dependent on the magnitude
of  (Huang et al., 2002; Martin et al., 1991).  is created by
pumping protons from the matrix to the inter-membrane space in
conjunction with electron transport through the respiratory chain,
Journal of Cell Science 123 (3)
Fig. 5. Analysis of mitochondrial import in an in vitro system and
following amino acid substitutions. (A)[35S]-labeled proteins translated in
reticulocyte lysate from the schematically represented constructs were
incubated with isolated mitochondria from chicken liver. The extent of import
was determined by resistance to PK digestion. Samples were dissolved in
sample buffer and resolved by SDS-PAGE followed by fluorography. Input
(5%); precursor (p) and mature (m) forms are indicated. (B)Hepatocytes and
astrocytes were transfected with EGFP chimeric constructs containing the first
50 N-terminal residues of chicken GS (pCh-50N-EGFP) or the 50 N-terminal
residues with substitutions of Tyr17Glu (pCh-50N-EGFPY17E), Ser7Ala (pCh-
50N-EGFPS7A) or Tyr17Ala (pCh-50N-EGFPY17A). M and C denote
mitochondrial and cytoplasmic localization, respectively. Substituted residues
are shown in bold.
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and facilitates import by exerting an electrophoretic effect on the
positively charged MTS. We examined whether the magnitude of
 of hepatocytes is different from that of astrocytes. We performed
live-cell imaging of hepatocytes and astrocytes stained with
tetramethyl rhodamine methyl ester (TMRM), a mitochondria-
specific fluorescent cation that accumulates in the mitochondrial
matrix according to . The acquired images were analyzed by a
computer-assisted method for automated quantification of 
(Koopman et al., 2008). Remarkably, the results showed that TMRM
intensity of hepatocytes is about 40% higher than that of astrocytes
and, therefore, that the  in astrocytes is substantially less
negative than that in hepatocytes (Fig. 6A,B). Further quantification
of the TMRM images also revealed that hepatocyte mitochondria
are more branched, larger and longer than those of astrocytes (Fig.
6C–E). Analysis by electron microscopy showed that hepatocyte
mitochondria are internally more complex, containing intricate
folding of the mitochondrial inner membrane (Fig. 6F). Given that
the inner membranes contain the respiratory chain components, it
is possible that the magnitude of  is a reflection of mitochondrial
morphology (Benard and Rossignol, 2008).
Altering the charge or length of the GS targeting signal
facilitates mitochondrial import in astrocytes
The magnitude of  required for mitochondrial import has been
shown to depend on the length and net positive charge of the
targeting sequence: proteins with a short or less positively charged
MTS require a higher electrical potential for import than do
proteins with a longer or a more positively charged MTS (Huang
et al., 2002; Martin et al., 1991). To identify more precisely the
targeting signal of GS, we inspected the N-terminal 50 residues by
secondary structure prediction programs (PSIPRED, HNN, Jpred,
SCRATCH and PredictProtein). The results revealed that, similarly
to human GS, whose crystal structure has recently been resolved
(Krajewski et al., 2008), the N-terminal residues of avian GS
comprise three structural elements: an -helix at the most N-terminal
region and two extended strands downstream to the -helix. Helical
wheel projection of the predicted -helical region (residues 2-19)
showed that, similarly to known MTSs, this region can form a
positively charged amphipathic -helix (Fig. 7A). We examined
whether GS N-terminal residues, which encompass the -helix
structure, constitute a functional MTS. Analysis of chimeric EGFP
constructs that contain the first 37 (pCh-N37-EGFP), 23 (pCh-N23-
EGFP) or 14 (pCh-N14-EGFP) residues of GS or a 50 amino acid
segment spanning between residues 35 and 84 (pCh-35-84-EGFP),
revealed that the first 23 residues, which include the complete -
helix structure, are indeed sufficient to confer mitochondrial
localization in hepatocytes and cytoplasmic localization in astrocytes
(Fig. 7B, see also supplementary material Fig. S1). This short
targeting sequence constitutes a weak MTS: it has particularly low
scores from MTS prediction programs (MitoProtII, PsortII, TargetP)
(e.g. with MitoProtII it scores 0.136 compared to the MTS of dogfish
GS that scores 0.692). It contains only three positive residues, all
of which are lysine, and two histidines that have a pKa of
approximately 6.0 and probably do not contribute positive charges
under physiological conditions.
Considering that the  in hepatocytes is more negative than in
astrocytes it is possible that the weak MTS provides a tool for
differential targeting of GS: In hepatocytes, the highly negative 
might exert a sufficiently strong pulling force to drive translocation
of GS, whereas in astrocytes,  might be below the threshold
required for GS import. We examined whether converting the
Fig. 6. Mitochondria of hepatocytes and astrocytes differ in morphology
and TMRM intensity. (A)Typical confocal images of mitochondria from
hepatocytes and astrocytes, stained with TMRM and used for statistical
analysis of mitochondrial morphology and fluorescence intensity. Image
processing of the background corrected image (COR) yielded a binary image
(BIN). Masking of the COR image with the BIN image was used to create an
intensity-coded image of the mitochondrial objects (MSK). Color coded scale
bar on the right indicates the intensity of TMRM fluorescence from blue (low
intensity) to red (high intensity). Quantification of the MSK image for
hepatocytes (black columns) and astrocytes (white columns) was used to
calculate (B) average mitochondrial TMRM intensity, (C) degree of
branching, (D) area and (E) aspect ratio. The individual values for hepatocyte
mitochondria are expressed as % of mean value for these cells in each graph.
Data for astrocytes is expressed as % of the mean observed in hepatocytes.
Error bars indicate s.e. ***P<0.001. For hepatocytes and astrocytes, a total of
12498 and 22884 objects (mitochondria) and 420 and 490 cells were analyzed,
respectively. (F) Electron microscope (EM) images of typical mitochondria in
hepatocytes (left panels) or astrocytes (right panels). Scale bars: 1m (upper
panels); 200 nm (lower panels).
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targeting signal of GS into a strong MTS, by elevating the net
positive charge or extending the size of the targeting sequence,
would compensate for a less-negative  and facilitate
mitochondrial targeting also in astrocytes. Indeed, substitution of
the histidine residues with arginine (pCh-50N-EGFPH15R and pCh-
50N-EGFPH8R, H15R), a positively charged residue under
physiological pH, resulted in mitochondrial localization in both
hepatocytes and astrocytes (Fig. 7C, see also supplementary material
Fig. S1). Similarly, extending the size of the MTS by including two
copies of the targeting sequence (pCh-N23  2-EGFP) facilitated
mitochondrial targeting also in astrocytes (Fig. 7D, see also
supplementary material Fig. S1). These findings suggest that avian
GS has evolved to include a weak MTS, which allows tissue-specific
targeting of GS by taking advantage of the differential magnitude
of .
Discussion
The most common means to target a protein to two different
subcellular localizations is to maintain two copies of the gene. This
is the case in Drosophila melanogaster, which contains two distinct
GS genes (Caizzi et al., 1990): one encodes a GS isoform that contains
a MTS and is targeted to the mitochondria, whereas the other encodes
an isoform that lacks a MTS and is retained in the cytoplasm (Caizzi
et al., 1990). Marine elasmobranchs and birds, which utilize the
ureosmotic and uricotelic systems for ammonia detoxification,
respectively, contain a single GS gene (Laud and Campbell, 1994;
Patejunas and Young, 1987). This gene apparently arose from a gene
sharing common ancestry with the Drosophila melanogaster
cytoplasmic GS (Pesole et al., 1991). Nevertheless, in these two
species, the GS enzyme is targeted to the mitochondria in liver cells
and cytoplasm in neural tissue. Analysis of the molecular mechanism
that underlies the differential targeting of GS in these two species
revealed that although the GS gene has been highly conserved during
evolution (Kumada et al., 1993), two distinct mechanisms for
differential targeting of GS have evolved independently.
In marine elasmobranchs, such as dogfish shark, previous studies
have shown that differential localization is achieved by tissue-
specific alternative splicing that generates two different GS
transcripts (Matthews et al., 2005). The liver transcript contains an
upstream alternative exon that is not present in the neural one and
leads to the formation of MTS. Here, extensive RT-PCR analysis
of the chicken GS transcript excluded the presence of an upstream
alternative exon, and sequence analysis of the GS protein showed
that the amino acid sequence of liver and brain GS is the same.
Furthermore, analysis of chimeric constructs that contain various
regions of the GS protein revealed that the capability to confer tissue-
specific subcellular localization is confined to the first 23 N-terminal
residues of chicken GS, which are sufficient to target a chimeric
EGFP construct to the mitochondria in hepatocytes and to the
cytoplasm in astrocytes. These findings indicate that tissue-specific
subcellular localization of avian GS is achieved by a novel
mechanism that can differentially localize an identical protein in
liver and brain cells.
Differential targeting of a single translation product might be
achieved by several possible mechanisms, one of which is post-
translational modification. Protein modification, such as
phosphorylation, might affect the accessibility of a targeting
sequence by altering its folding or ability to interact with another
protein or by directly modulating its targeting properties (Karniely
and Pines, 2005). Protein phosphorylation activates, for example,
the cryptic MTS of the cytochrome P450 family member CYP2B1
(Anandatheerthavarada et al., 1999), enhances the mitochondrial
import of the glutathione S-transferase protein (Robin et al., 2003),
but inhibits the mitochondrial import of the yeast protein YNK1
(nucleotide diphosphate kinase 1) (Amutha and Pain, 2003). The
possibility that differential targeting of GS involves the function of
a tissue-specific kinase was examined by amino acid substitutions.
Our results showed that although substitution of Tyr17 with the
phosphor-mimetic Glu residue was sufficient to impair
mitochondrial import in hepatocytes, substitution of Tyr17 and Ser7
with Ala, did not facilitate mitochondrial import in astrocytes. In
addition, MS/MS analysis revealed that apart from acetylation of
Ala at position 2 in GS from both liver and brain, there are no other
post-translational modifications in the sequenced fragments. These
findings suggest that tissue-specific subcellular localization is not
achieved by post-translational modification of the GS protein.
Translocation of proteins into the mitochondrial matrix is
ultimately dependent on a sufficiently large electrochemical proton
gradient across the mitochondrial inner membrane. It has been
suggested that the electrophoretic effect produced by  on MTS
leads to an active pulling mechanism that includes catalyzed
unfolding of protein domains (Huang et al., 2002; Shariff et al.,
2004). The magnitude of  required for import is dependent on
the length and/or net positive charge of the mitochondrial targeting
signal. Proteins with a ‘strong’ signal, which is characterized by
the presence of basic amino acids and the absence of acidic ones,
can be imported at a moderately negative , whereas proteins
with a ‘weak’ signal, characterized by a low content of positive
charged residues, require higher  (Martin et al., 1991). In
addition, proteins with a long targeting signal (i.e. 40-50 residues)
are not dependant on a highly negative  for import, possibly
Journal of Cell Science 123 (3)
Fig. 7. Altering the charge or length of GS targeting signal facilitates
mitochondrial import in astrocytes. (A)Helical wheel projection of amino
acids 2-19 of chicken GS. Hydrophobic, polar and charged amino acids are
colored black, blue and red, respectively. Hepatocytes and astrocytes were
transfected with EGFP fused chimeric constructs containing: (B) the first 50
N-terminal residues of chicken GS, shorter segments of 37 (pCh-37N-EGFP),
23 (pCh-23N-EGFP) or 14 (pCh-14N-EGFP) residues, the 50 residues
spanning from amino acid 53 to 84 (pCh-35-84-EGFP); (C) the 50 N-terminal
residues with specific substitutions (shown in bold) of His15Arg (pCh-50N-
EGFPH15R) or both His8Arg and His15Arg (pCh-50N-EGFPH8R, H15R); or (D)
two juxtaposed copies of the first 23 residues (pCh-232N-EGFP). Predicted
-helixes and -strands are indicated by cylinders and arrows, respectively. M
and C denote mitochondrial and cytoplasmic localization, respectively.
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because they reach the matrix at the initial interaction with the import
machinery and become unfolded by the mitochondrial Hsp70
(Huang et al., 2002; Shariff et al., 2004). Recently, we have shown
that dual-targeted mitochondrial proteins tend to have a weaker MTS
than exclusive mitochondrial proteins (Dinur-Mills et al., 2008).
GS is an example in which the weak MTS has functional
significance. Analysis of the GS N-terminal residues revealed that
the targeting signal is relatively short and is encompassed within
the first 23 residues. This region forms, according to prediction
programs and to the crystal structure of the highly homologous
human GS, an -helical structure. Imposition of this region onto
an -helical wheel projection shows that it has the properties of an
amphipatic -helical MTS with a hydrophilic face that contains
some positive and polar residues and lacks negative ones. This short
targeting sequence established a weak MTS, as judged by the
particularly low scores given by MTS prediction programs and by
the low number of positively charged residues. In contrast to the
canonical MTS of Su9, this weak MTS was incapable of directing
mitochondrial import in a standard in vitro import reaction.
Considering that a weak MTS is dependant on a highly negative
 for import, we decided to examine the magnitude of  of
liver and brain cells. Remarkably, our results revealed that  in
hepatocytes is considerably more negative than in astrocytes. This
finding represents, to the best of our knowledge, the first example
of cell-type-specific differences in . Changes in  have been
previously observed in neurological disorders (Abou-Sleiman et al.,
2006; Mortiboys et al., 2008), aging cells (Sugrue and Tatton, 2001)
and tumors. A more negative  has been detected in a variety of
carcinomas (Chen, 1988; Fantin et al., 2002; Fantin et al., 2006)
and in chemically induced and oncogene-induced malignant
transformation in various cell types (Liang et al., 1999; Zarbl et al.,
1987). The more negative  in tumor cells has been attributed to
the shift in glucose metabolism: normal cells produce most of the
ATP from glucose through oxidative phosphorylation whereas many
cancer cells exhibit lower oxidative phosphorylation activity and
produce ATP by conversion of glucose to lactate. This change in
glucose metabolism is causatively related to the more negative 
in tumor cells (Fantin et al., 2006). Liver is the major organ involved
in glucose homeostasis by means of gluconeogenesis (i.e., glucose
production from precursor compounds such as lactate) and
glycolysis. A highly negative  in liver cells might be functionally
related to the complex metabolic functions exerted by the cells, but
might also reflect liver mitochondria ultrastructure, which exhibits
a larger surface area (Benard and Rossignol, 2008).
The possibility that a weak MTS provides a crucial tool for
differential targeting of GS was assayed by converting the targeting
signal of GS into a strong MTS. Our results clearly showed that
elevation of the net positive charge of the targeting sequence, by
substitution of one or two histidine residues with arginine, or by
extending the size of the MTS through including two copies of the
targeting sequence, abolished the capability to confer tissue-specific
subcellular localization. Under these conditions, the chimeric
protein was mitochondrial in both liver and brain cells. Our results
suggest that uricotelic species have evolved by the selection of a
weak MTS to the otherwise highly conserved GS enzyme. This
targeting sequence allows taking advantage of the tissue-specific
differences in  and directing the GS protein to the mitochondria
in liver cells and to cytoplasm in brain. The functional link between
MTS properties and the magnitude of  might provide a
mechanistic basis for the redirection of cellular protein under
physiological conditions in which  is altered.
Materials and Methods
Plasmid construction
Chimeric EGFP plasmids were constructed by using first strand cDNA generated from
RNA of chicken liver cells. pEGFP-Ch-50C was constructed by PCR amplification of
chicken liver cDNA using the following primers (underlined residues indicate
restriction sites): 5-TGTAAGCTTAGCATCCGCATCCCACG-3 and 5-ATG-
GATCCTACGGGGAGCACGGGG-3 and cloning into pEGFP-C3 (Clontech). All
other chimeric EGFP plasmids were constructed by cloning of PCR products into
pEGFP-N1 (Clontech). The following primers were used to amplify chicken cDNA:
For pCh-50N-EGFP 5-TGTAAGCTTGGAGCCGAGCGTGGGAG-3 (primer A)
and 5-ATGGATCCTCGTGGTCCAGAGTGCGG-3 (primer B); for pCh-37N-EGFP
primer A and 5-TAGGATCCCCAGTCCCGTCGATCCA-3; for pCh-23N-EGFP
primer A and 5-TAGGATCCCCCTGCGGCAGCTTC-3; for pCh-14N-EGFP primer
A and 5-ATGGATCCTTGATGGCTTTGCTCAGGTG-3; for pCh-35-84-EGFP
primer A and 5-TAGGTACCCATGGCTGCGGAGGTC-3 as well as primer B and
5-TAGGTACCGGGGAGCACCTCCGCTG-3. For plasmid pCh-232N-EGFP,
oligonucleotides spanning residues 2-23 were inserted into BamHI site of plasmid pCh-
23N-EGFP. For single amino acid substitution a two-step method was employed: in
the first step two PCR products were generated using pCh-50N-EGFP as template and,
in the second step, the PCR products were amplified using primers A and B. The
following primers were used for the first round of amplification: For pCh-50N-
EGFP(Y17E) primer A and 5-GATGGCTTATCAAGCACATGGAGATGAAGCT-
GCC-3 as well as primer B and 5-GGCAGCTTCATCTCCATGTGCTTGAT-3; for
pCh-50N-EGFP(S7A) primer A and 5-GGCGAGCGCCCACCTGAG-3 as well as
primer B and 5-CTCAGGTGGGCGCTCGCC-3; for pCh-50N-EGFP(Y17A) primer
A and 5-GATGGCTTATCAAGCACATGGCCATGAAGCTGCC-3 as well as
primer B and 5-GGCAGCTTCATGGCCATGTGCTTGAT-3; for pCh-50N-
EGFP(H8R) primer A and 5-GCGAGCTCCCGCCTGAG-3 as well as primer B and
5-CTCAGGCGGGAGCTCGC-3. For plasmid pCh-50N-EGFPH8R, H15R, with
double amino acid replacement, the PCR fragments were generated using pCh-50N-
EGFP(H8R) as template with primer A and 5-GCAAAGCCATCAAGCGCATGTAC-
3 as well as primer B and 5-GTACATGCGCTTGATGGCTTTGC-3. Plasmid pDf-
MTS-EGFP is described elsewhere [pL-GS-EGFP (Matthews et al., 2005)]. Plasmid
pGS, which contains the entire GS coding sequence under the control of Sp6, was
created by PCR amplification of first strand cDNA from chicken liver using primers
A and 5-TGTAAGCTTGCATGCCTGCAGGTC-3 and cloning into pGEM4
(Promega). Plasmid pSu9-GS was generated by replacing a NcoI/BglII fragment in
plasmid pGS with a PCR fragment obtained by amplification using pSu9-DHFR as
template with the primers 5-TACCATGGACAAAATGGCCTCCACTCG-3 and 5-
TAAGATCTCCGTGGAAGAGTAGGCG-3. Plasmid pGS-DHFR was generated by
replacing a AgeI/NotI fragment in plasmid pCh-50N-EGFP with a PCR fragment
obtained by amplification using pSu9-DHFR as template with the primers 5-ATAC-
CGGTTCGACCATTGAACTGCATCG-3 and 5-ATGCGGCCGCCTGGG TAT -
TTTGG-3. The resulting plasmid was used as template to generate a PCR fragment
with primer A and 5-TGTAAGCTTCAGGGGGAGGTGTGGGAGG-3, which was
cloned into pGEM4. The cloning details can be obtained upon request. All primers
were purchased from Sigma. In all plasmids the cloned region was confirmed by
sequencing. Plasmid DNA was prepared using the NucleoBond PC500 (Macherey-
Nagel) plasmid preparation kit.
Subcellular fractionation and western blot analysis
Liver or brain tissues of chicken embryos (E18) were excised, suspended in isotonic
HIM buffer (200 mM mannitol, 70 mM sucrose, 1 mM EGTA, 10 mM HEPES-KOH
pH 7.4) including 0.1% BSA and homogenized in a Dounce homogenizer by five
strokes with pestle A and two strokes with pestle B. The homogenate was centrifuged
at 1000 g for 10 minutes. The supernatant was centrifuged at 12,000 g for 15 minutes
to obtain the mitochondrial pellet and the cytoplasmic supernatant. The mitochondrial
pellet was washed twice at 12,000 g and resuspended in HIM. The cytoplasmic
supernatant was centrifuged at 120,000 g for 60 minutes and the pellet was discarded.
Total protein extract was obtained by homogenization in Passive Lysis Buffer
(Promega) by five strokes with pestle A and 20 strokes with pestle B, sonication for
5 minutes and centrifugation at 20,000 g for 15 minutes. All steps were carried out
at 4°C. Equal portions of total, cytoplasmic and mitochondrial fractions were resolved
on 10% SDS-PAGE gel. For western blot analysis, antibodies against tubulin (DM
1A; Sigma), mHsp60 (LK-2; Sigma), GS (Gorovits et al., 1997) or phosphotyrosine
(PY20; Santa Cruz Biotechnology) were used. The corresponding horseradish-
peroxidase-conjugated secondary antibodies were used, and the cross-reactivity was
visualized by the enhanced chemoluminescence (ECL) procedure (Pierce).
Immunoprecipitation and mass spectrometry sequencing
For immunoprecipitation, protein extracts (0.5 mg) were precleared by incubation
for 16 hours at 4°C with pre-immunserum bound to protein-A-Sepharose (Amersham).
Cleared extracts were immunoprecipitated with protein-A-Sepharose bound to anti-
GS antibodies overnight at 4°C. The immunoprecipitated proteins were separated on
10% SDS-PAGE and analyzed by western blotting or stained with Coomassie blue.
The Coomassie-blue-stained gel slices, containing the GS protein band, were
incubated with either trypsin, AspN or GluC, and MS carried out with Qtof2
(Micromass, England) using a nanospray attachment. Data analysis was done using
the biolynx package (Micromass, England) and database searches were performed
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with the Mascot package (Matrix Science, England). Similarity searches of sequences,
determined via manual analysis, were carried out with the GCG Wisconsin Package
Version 10.3 (Accelrys, San Diego, CA) and Blast search in the NCBI data bank
(http://www.ncbi.nlm.nih.gov).
RNA preparation, northern blot and RT-PCR analysis
Total RNA was prepared using TriPure isolation reagent (Roche) and first strand
cDNA was synthesized following treatment with DNase I (Fermentas), using the Iscript
cDNA synthesis kit (Bio-Rad). For RT-PCR analysis, first strand cDNA was amplified
by PCR (30 cycles) using the following primers: 5-TGCCCGCAGCCCAGCCCA-
3 (primer 1), 5-GTGTCTGTGGGCACGATGCC-3 (primer for exon 7), 5-
CTCTTGGGTTCGTGGTCCA-3 (primer 2), 5-CCCGAAGCTCACCCCACTG-3
(primer 3), 5-GGGGTCACATGAAGGGGTT-3 (primer 4), 5-TTTCA AGGCT -
ATCAGCACG-3 (primer 5), 5-CGGGCTCAGAAGGTGTTA-3 (primer 6) and 5-
ATGAAGGCTGTTGCTTGGC-3 (primer 7). The PCR products were fractionated
in 1.2% agarose gel and visualized with ethidium bromide. For northern blot analysis,
RNA was denatured by heating at 60°C for 10 minutes in 2.2 M formaldehyde and
50% formamide, and fractionated in 1.2% agarose gel containing 2.2 M formaldehyde.
The fractionated RNA was transferred to a nitrocellulose filter, hybridized with a GS
probe labeled with [32P] by the random primer DNA labeling mix (Biological
Industries, Israel) and visualized by autoradiography.
Monolayer cultures, transfection and immunostaining
Liver and brain tissues were isolated under sterile conditions from chicken embryos
(E18) and primary cultures of astrocytes and hepatocytes were prepared according
to published protocols (Mayo et al., 2008; Tarlow et al., 1977). For astrocytes, cerebral
cortices were dissociated with trypsin and cultured for 10 days on coverslips coated
with poly-L-lysine (0.1 g/l) in DMEM supplemented with 10% FCS. For hepatocytes,
the liver tissue was dissociated with collagenase and cultured in 1:1 ratio of H12
medium and DMEM supplemented with 10% FCS and 10% essential and non-
essential amino acids in the presence of 5 g/ml insulin. The cells were transfected
with DNA (1 g per 5105 cells) using the jetPEI (Polyplus transfection) according
to the manufacturer’s instructions. Then, cells were stained after 48 hours by incubation
with 250 nM MitoTracker Red (Molecular Probes) for 15 minutes at 37°C and fixed
with 4% paraformaldehyde, according to published protocols. Confocal imaging was
performed using Zeiss R510 confocal laser scanning microscope. Excitation was
performed with an argon laser set to 488 nm and emission was detected with a 525±15
nm band-pass barrier filter. Red fluorescence for mitochondria was examined using
568 nm excitation light, and emission was detected with a 580-625 nm filter. For
immunostaining, the MitoTracker-stained and fixed cells were incubated with anti-
GS antibodies and subsequently with FITC-conjugated goat anti-rabbit antibodies
(Jackson ImmunoResearch). Confocal imaging was performed as described above.
Mitochondrial morphology and membrane potential analysis
For electron microscopy, hepatocytes and astrocytes were harvested and fixed with
2.5% glutaraldehyde in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM
KH2PO4, pH 7.4) and post-fixed in 1% OsO4 in PBS. After dehydration in graded
ethanol solutions, the samples were embedded in glycid ether (Serva). Ultrathin
sections (~ 0.1 m) were stained with uranyl acetate and lead citrate and examined
in a Jeol 1200 EX TEM. For live-cell imaging, hepatocytes and astrocytes grown on
coverslips were incubated with 100 nM of tetramethyl rhodamine methyl ester
(TMRM; Molecular probes) for 25 minutes in a dark humidified incubator at 37°C.
After incubation, the coverslips were washed with PBS and mounted on an imaging
chamber filled with HT solution (132 mM NaCl, 4.2 mM KCl, 1 mM MgCl2, 1 nM
CaCl2, 5.5 mM D-glucose, 10 mM HEPES, pH 7.4). Confocal images were acquired
using Zeiss R510 confocal laser scanning microscope. Excitation was performed using
568 nm excitation light, and emission was detected with a 560 nm long-pass barrier
filter. The confocal images were analyzed by computer-assisted methods as described
before (Koopman et al., 2008). The parameters examined were mitochondrial
branching, area, aspect ratio (AR, which reflects the ratio of mitochondrial length to
width) and levels of TMRM fluorescence.
In vitro import into isolated mitochondria
The pGEM4 constructs were used as templates for in vitro SP6 transcription/translation
carried out with a TNT Coupled Reticulocyte Lysate System (Promega) in the presence
of [35S]methionine. In some reactions, labeled proteins were denatured in 8 M urea
and 20 mM HEPES-KOH pH 7.4, at room temperature for 2 hours before the import
reaction. Coupled translation and import was performed as described before (Knox
et al., 1998) using GS mRNA transcribed from pGS. Import reactions into isolated
mitochondria (100 g per reaction) were carried out in 200 l SI buffer (0.6 M
mannitol, 50 mM HEPES-KOH pH 7.4, 80 mM KCl, 10 mM MgAc, 2 mM KH2PO4,
2 mM EDTA, 2 mM MnCl2 and 3% BSA) for 60 minutes at 30°C. The reaction was
started by the addition of buffer B (2 mM ATP, 4 mM NADH, 100 g/l creatine
kinase and 4.5 mM creatine phosphate) and 2 l of labeled protein. Import was stopped
by diluting the reaction fivefold in ice-cold SHKCL medium (0.6 M sorbitol, 80 mM
KCl and 50 mM HEPES-KOH pH 7.4), which included 0.1 g/ml valinomycin, with
or without 50 g/ml proteinase K. The protease was inactivated by the addition of
20 mM PMSF for 5 minutes on ice. The samples were centrifuged at 12,000 g for
20 minutes. The mitochondrial pellet was resuspended in SHKCL buffer and
centrifuged at 12,000 g for another 20 minutes. The final mitochondrial pellet was
dissolved in sample buffer, boiled for 5 minutes at 95°C and subjected to SDS-PAGE.
Signals of radiolabeled proteins were detected by autoradiography.
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